Latest News

From Adlego Biomedical

News

Adlego participate in the fight against Corona virus

Adlego participate in the fight against Corona virus

Adlego Biomedical AB participates in two projects financed by the European Commision to evaluate DNA vaccines and antivirals designed to protect against SARS-CoV-2 infections. The OpenCorona project is lead by Professor Matti Sällberg at the Karolinska...

read more
Nya vaccin mot hepatit

Nya vaccin mot hepatit

Magnus Johansson har fått 4,8 miljoner kronor för att utveckla nya vaccin mot hepatit B, hepatit D och hepatit C. Miljontals människor drabbas varje år av dessa sjukdomar och får kroniska besvär. Trots att alla tre skadar levern krävs olika sorters vaccin och...

read more
The use of iPrecio pumps for infusion

The use of iPrecio pumps for infusion

For a long period of time osmotic minipumps from Alzet has been available for infusion of compounds in drug developing studies. These pumps are, however, limited in volume and flexibility and therefore we have investigated the use of the programmable iPrecio pumps....

read more
Kanceras HDAC6-projekt tilldelas anslag från Vinnova

Kanceras HDAC6-projekt tilldelas anslag från Vinnova

Kancera har av Sveriges innovationsmyndighet VINNOVA tilldelats ett anslag om totalt 2,000,000 kronor riktat till projekt som kan utvecklas till nya starka innovationer. Delutbetalningar av anslaget sker vid fyra tillfällen under det två-åriga projektet.  ...

read more
Tumour models for cancer research

Tumour models for cancer research

Since 2008 we have performed numerous tumour studies to determine the effect of drug candidates. Now, we have compiled information about the growth rates of the models we have used to help customers select which model may be most suitable for their drug candidate....

read more
Combination therapy of tumors

Combination therapy of tumors

Since it is common practice to combine irradiation of tumours in humans with drug treatment we have developed procedures that works on nude mice xenotransplanted with human tumour cells. The figure below shows an example in which HCT116/GFP tumours responded to...

read more